Concept information
Preferred term
Nateglinide
Type
-
mesh:Descriptor
Definition
- A phenylalanine and cyclohexane derivative that acts as a hypoglycemic agent by stimulating the release of insulin from the pancreas. It is used in the treatment of TYPE 2 DIABETES.
Broader concept
Entry terms
- 105746-37-0 ((D-Phe)-isomer)
- 105816-04-4 (Nateglinide)
- 105816-06-6 ((cis,D-Phe)-isomer)
- 41X3PWK4O2
- D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-
- Nate-Glinide
- Senaglinide
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
105746-37-0 ((D-Phe)-isomer)
-
105816-04-4 (Nateglinide)
-
105816-06-6 ((cis,D-Phe)-isomer)
-
41X3PWK4O2
-
D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-
URI
http://data.loterre.fr/ark:/67375/JVR-GSC1JSF2-B
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}